VISCHER advised CITIC on all Swiss law matters. The team was led by Benedict F. Christ (partner, corporate/M&A – pictured) and included Lukas Zuest (counsel, head China Desk, corporate/M&A), Aleksandra Simic (junior associate, corporate/M&A), Marc Ph. Prinz (partner, employment), Jeannine Dehmelt (associate, employment), and Roland M. Mueller (partner, notary public).
Homburger acted as Swiss counsel to ARYZTA in connection with the transaction. The team was led by partner Claude Lambert (Corporate / M&A - pictured) and comprised associates Marc Hanslin (Corporate / M&A) and David
The Walder Wyss team was led by Markus Vischer (Partner, Corporate/M&A) and Olivia Feusi (Managing Associate, Corporate/M&A) and further included Timon Nydegger (Associate, Corporate/M&A), Ueli Sommer (Partner, Employment) and
VISCHER advised MCAM as lead counsel. The team was led by partner Felix W. Egli (Corporate/M&A - pictured) and included partner Christoph Niederer (Tax), managing associate Thomas Steiner-Krizaj (Corporate/M&A) , counsel Peter
Homburger acted as Swiss counsel to Picanol in connection with the transaction. The team comprised partner Dieter Gericke (pictured) and associate Marc Hanslin (both Corporate / M&A). Stibbe BV/SRL (Jan Peeters) acted as Belgian
As reported by Mergermarket, Partners Group general counsel Andreas Knecht (pictured) followed the transaction.
Lenz & Staehelin with partner Benoît Merkt (pictured) assisted the Geneva-based organization the Global Antibiotic Research & Development Partnership (GARDP Foundation) in connection with the Agreement signed with the Federal Council on March 10, 2021, relating to the
Citi is acting as financial advisor to Roche and Sidley Austin is acting as legal counsel to Roche. J.P. Morgan Securities is acting as exclusive financial advisor to GenMark and DLA Piper LLP is
Advestra acted as Swiss legal counsel to H.I.G. Capital in the transaction. The team included Alexander von Jeinsen (pictured), Daniel Raun and Anna Capaul (all Corporate | M&A) as well as Markus Mü
Walder Wyss advised the shareholders of HUBERLAB.AG on the sale to Calibre Scientific. The team was led by Alexander Gutmans (Partner, Corporate/M&A and Venture Capital - pictured) and included Robert Desax (Partner,
